Showing results (11-20 of 570) with videos related to
Sort By:
Pageof 57
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 10, 2022
Monoclonal Antibody Therapies Beyond Complement for NMOSD and MOGADVyanka Redenbaugh, Eoin P FlanaganChemistry and Physics of Lipids|August 1, 1995
Mass spectrometric evidence for the anomalous chemical behavior of 11-dehydrothromboxane B2A Ferretti, V P FlanaganThe Ulster Medical Journal|September 18, 1999
Acute medical bed usage by nursing home residentsT R Beringer, P FlanaganBiochimica Et Biophysica Acta|August 6, 1990
Modification of prostaglandin metabolism in vivo by long-chain omega-3 polyunsaturatesA Ferretti, V P FlanaganLipids|May 1, 1979
Simultaneous mass spectrometric measurement of prostaglandins E1 (PGE1) and PGE2 with a deuterated internal standardA Ferretti, V P FlanaganMultiple Sclerosis (Houndmills, Basingstoke, England)|January 25, 2025
Testing for myelin oligodendrocyte glycoprotein antibodies: Who, what, where, when, why, and howAdrian Budhram, Eoin P FlanaganHandbook of Clinical Neurology|January 12, 2026
The evolution and current status of anti-B-cell therapies in autoimmune neurologic diseasesAlbert Aboseif, Eoin P FlanaganHandbook of Clinical Neurology|March 17, 2024
Paraneoplastic/autoimmune myelopathiesMayra Montalvo, Eoin P FlanaganLipids|February 1, 1977
Tissue variation in hydrocarbon composition in the rabbitA Ferretti, V P FlanaganPageof 57